Bendamustine-induced "flagellate dermatitis"

The term "flagellate erythema" after bleomycin therapy was described as bleomycin-induced linear hyperpigmentation. Since then, this pattern has not been related to any other chemotherapeutic regimen. We report a rare patient with chronic lymphocytic leukemia who developed "flagellate...

Full description

Saved in:
Bibliographic Details
Published in:Dermatology online journal 2012-11, Vol.18 (11), p.12-12
Main Authors: Mahmoud, Bassel H, Eide, Melody J
Format: Article
Language:English
Subjects:
Antineoplastic Agents, Alkylating - adverse effects
Antineoplastic Agents, Alkylating - therapeutic use
Bendamustine Hydrochloride
Drug Eruptions - etiology
Drug Eruptions - pathology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Male
Middle Aged
Nitrogen Mustard Compounds - adverse effects
Nitrogen Mustard Compounds - therapeutic use
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The term "flagellate erythema" after bleomycin therapy was described as bleomycin-induced linear hyperpigmentation. Since then, this pattern has not been related to any other chemotherapeutic regimen. We report a rare patient with chronic lymphocytic leukemia who developed "flagellate dermatitis" induced by bendamustine. Chemotherapy induced "Flagellate Dermatitis" is a rare finding reported only after bleomycin therapy. We describe the first case with this characteristic eruption pattern after administration of bendamustine.
ISSN:1087-2108
1087-2108
DOI:10.5070/D36QJ3649F